PACIRA BIOSCIENCES, INC. Asset Retirement Obligation, Liabilities Incurred
PACIRA BIOSCIENCES, INC. (PCRX) reported Asset Retirement Obligation, Liabilities Incurred of $400.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-28.
Discontinued › Notes › Asset Retirement Obligations
us-gaap:AssetRetirementObligationLiabilitiesIncurred · last filed 2018-02-28
- PACIRA BIOSCIENCES, INC. asset retirement obligation, liabilities incurred for the quarter ending 2017-12-31 was -$253.00K.
- PACIRA BIOSCIENCES, INC. asset retirement obligation, liabilities incurred for the quarter ending 2017-09-30 was $278.00K.
- PACIRA BIOSCIENCES, INC. asset retirement obligation, liabilities incurred for fiscal 2017 was $400.00K.
| Period end | Asset Retirement Obligation, Liabilities Incurred 3 month | Asset Retirement Obligation, Liabilities Incurred 6 month | Asset Retirement Obligation, Liabilities Incurred 9 month | Asset Retirement Obligation, Liabilities Incurred 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$253.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $25.00K derived: sum of 2 quarters · filed 2018-02-28 | $400.00K 10-K · filed 2018-02-28 | |
| 2017-09-30 | $278.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $653.00K 10-Q · filed 2017-11-08 | ||
| 2017-06-30 | $375.00K 10-Q · filed 2017-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |